{
    "clinical_study": {
        "@rank": "112440", 
        "acronym": "KINECIG", 
        "arm_group": [
            {
                "arm_group_label": "Own Brand cigarette", 
                "arm_group_type": "Active Comparator", 
                "description": "Smoke Own Brand cigarette, 15 puff of cigarette."
            }, 
            {
                "arm_group_label": "One High 2,4% nicotine", 
                "arm_group_type": "Experimental", 
                "description": "Smoke electronic cigarette One High 2,4% nicotine for a day, 15 puff of e-cigarette."
            }, 
            {
                "arm_group_label": "Original 7,4 mg nicotine", 
                "arm_group_type": "Experimental", 
                "description": "Smoke electronic cigarette Original 7,4 mg nicotine for a day. 15 puff of e-cigarette."
            }, 
            {
                "arm_group_label": "Nicotine Free", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Smoke electronic cigarette nicotine free (15 puff)"
            }, 
            {
                "arm_group_label": "EGO 9mg", 
                "arm_group_type": "Experimental", 
                "description": "Smoke electronic cigarette EGO for a day (15 puff)"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the present study is to compare serum nicotine levels of  different e-Cigarette\n      strength with usual cigarettes. Serum levels of carcinogenic and toxic substances will be\n      also compared."
        }, 
        "brief_title": "Pharmacokinetic Profile of Toxic Substances and Nicotine in Electronic Cigarettes", 
        "completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "condition": "Tobacco Abuse Smoke", 
        "condition_browse": {
            "mesh_term": "Tobacco Use Disorder"
        }, 
        "detailed_description": {
            "textblock": "The study is randomised cross-over trial designed to compare: 1) serum nicotine levels of\n      four different e-Cigarette strength ; 2) Serum levels of carcinogenic and toxic substances\n      will be also compared. Participants will be  requested to abstain from smoking and alcohol\n      from 20:00 on the night before each study day and from food and caffeine for at least 1 h\n      before the session. On arrival at the study centre, carbon monoxide (CO) will be measured in\n      participants' expired breath. If CO will be less than 15 parts per million (ppm), the\n      assigned study treatment will be allocated; however, if CO was > 15 ppm or they will report\n      smoking in the previous 12 h, participants will be rescheduled wherever possible to a\n      subsequent session.\n\n      On the first study day, participants will be  randomised to use one of five ordered\n      conditions (each separated by 3 day): ENDDs (fourth generation) containing nicotine 2,4%;\n      ENDDs (second generation) containing nicotine 7,4 mg;  ENDDs containing nicotine 9 mg; ENDDs\n      nicotine free; their usual cigarette.  Additionally participants will be trained to use an\n      electronic cigarette. The following tests will be completed at the each visits: Aldehydes;\n      ROM/TOS; Total thiols; Nicotine; Hydroxypyrene; Cotinine; 1,3-butadiene; Acrylonitrile.\n      After, they will be cannulated and serial venous blood samples for Aldehydes; ROM/TOS; Total\n      thiols; Nicotine will be collected at 0.5, 2, 5, 15, 30 and 60 min after being instructed to\n      take 10 puffs. Additionally, levels of carbon monoxide in exhaled breath (eCO) will be\n      measured 0.5, 2, 5, 15, 30 and 60 min after being instructed to take 10 puffs. At 60 min,\n      after being instructed to take 10 puffs, urine sample for Hydroxypyrene; Cotinine;\n      1,3-butadiene; Acrylonitrile will be collected. Participants then will leave the study\n      centre with instructions to continue their usual daily activities  and to use the study\n      product regularly (for at least 10 hrs) and freely throughout the day.  At bedtime and after\n      the puffing chronic phase, when participants will use the study product regularly for at\n      least 10 hrs, urine sample for Hydroxypyrene; Cotinine; 1,3-butadiene; Acrylonitrile will be\n      collected. Participants will be allowed to smoke as they will wish once these measures will\n      be collected and during the 3-day washout period between each study day."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  20 regular smokers (smoking \u2265 15 factory-made cigarettes per day for at least the\n             past 10 years and not currently attempting to quit smoking or wishing to do so in the\n             next 30 days, CO  > 10 parts per million ) will be recruited from the local Hospital\n             staff in Catania, Italy.\n\n        Exclusion Criteria:\n\n          -  people who reported recent myocardial infarction, angina pectoris or other serious\n             medical conditions (diabetes mellitus, severe allergies, poorly controlled asthma or\n             other airways disease, poorly controlled psychiatric disorders or current chemical\n             dependence other than nicotine) and\n\n          -  pregnancy,\n\n          -  breastfeeding,\n\n          -  blood pressure > 180 mm Hg systolic and/or 100 mm Hg diastolic,\n\n          -  weight < 45 or > 120 kg, or\n\n          -  current use of any other smoking cessation medications"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01665066", 
            "org_study_id": "KINECIG UNICT 526 /12 (Polosa)", 
            "secondary_id": "Polosa-Caponnetto 2012"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Own Brand cigarette", 
                    "One High 2,4% nicotine", 
                    "Original 7,4 mg nicotine", 
                    "Nicotine Free", 
                    "EGO 9mg"
                ], 
                "description": "Smoke, 15 puff of, Own Brand cigarettes;", 
                "intervention_name": "Own Brand cigarette", 
                "intervention_type": "Other", 
                "other_name": "Own Brand cigarette"
            }, 
            {
                "arm_group_label": [
                    "Own Brand cigarette", 
                    "One High 2,4% nicotine", 
                    "Original 7,4 mg nicotine", 
                    "Nicotine Free", 
                    "EGO 9mg"
                ], 
                "description": "Smoke, 25 puff, of electronic cigarette one high 2,4% nicotine", 
                "intervention_name": "one high 2,4% nicotine", 
                "intervention_type": "Other", 
                "other_name": "Categoria electronic cigarette one high 2,4% nicotine"
            }, 
            {
                "arm_group_label": [
                    "Own Brand cigarette", 
                    "One High 2,4% nicotine", 
                    "Original 7,4 mg nicotine", 
                    "Nicotine Free", 
                    "EGO 9mg"
                ], 
                "description": "Smoke, 15 puff, of Categoria electronic cigarette 7,4 mg nicotine", 
                "intervention_name": "original 7,4 mg nicotine", 
                "intervention_type": "Other", 
                "other_name": "Categoria electronic cigarette 7,4 mg nicotine"
            }, 
            {
                "arm_group_label": [
                    "Own Brand cigarette", 
                    "One High 2,4% nicotine", 
                    "Original 7,4 mg nicotine", 
                    "Nicotine Free", 
                    "EGO 9mg"
                ], 
                "description": "smoke, 15 puff, of electronic cigarette nicotine free", 
                "intervention_name": "nicotine free", 
                "intervention_type": "Other", 
                "other_name": "categoria electronic cigarette nicotine free \"mint\"."
            }, 
            {
                "arm_group_label": [
                    "Own Brand cigarette", 
                    "One High 2,4% nicotine", 
                    "Original 7,4 mg nicotine", 
                    "Nicotine Free", 
                    "EGO 9mg"
                ], 
                "description": "smoke, 15 puff, of electronic cigarette Ego 9 mg", 
                "intervention_name": "Ego 9mg", 
                "intervention_type": "Other", 
                "other_name": "electronic cigarette Ego 9 mg nicotine"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Nicotine", 
                "Nicotine polacrilex"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 12, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Catania", 
                    "country": "Italy", 
                    "zip": "95124"
                }, 
                "name": "Centro per la Prevenzione e Cura del Tabagismo"
            }
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "5", 
        "official_title": "Pharmacokinetic Profile of Toxic Substances and Nicotine in Electronic Cigarettes: a Randomised Cross-over Trial KINECIG", 
        "overall_official": {
            "affiliation": "University of Catania", 
            "last_name": "Riccardo Polosa, MD, Phd", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "participants will be cannulated and serial venous blood samples for Nicotine will be collected at 0.5, 2, 5, 15, 30 and 60 min after being instructed to take 10 puffs of cigarette", 
            "measure": "nicotine pharmacokinetic", 
            "safety_issue": "No", 
            "time_frame": "0 sec, 30 second, 2 minutes, 5 minutes, 15 minutes, 30 minutes, 60 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01665066"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Universita degli Studi di Catania", 
            "investigator_full_name": "Riccardo Polosa", 
            "investigator_title": "Professor of Internal Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": {
            "PMID": "22529223", 
            "citation": "Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L. Nicotine levels in electronic cigarettes. Nicotine Tob Res. 2013 Jan;15(1):158-66. doi: 10.1093/ntr/nts103. Epub 2012 Apr 22."
        }, 
        "secondary_outcome": {
            "description": "Compare serum levels of carcinogenic and toxic substances of \"Categoria\" electronic cigarettes labelled Original 7,4 mg nicotine , Disposable \"Categoria\" electronic cigarettes labelled One 2,4% nicotine, Disposable \"Categoria\" electronic cigarettes labelled nicotine free, electronic cigarettes labelled Ego 9mg nicotine  with usual cigarettes.", 
            "measure": "Serum levels of carcinogenic and toxic substances (Aldehydes; ROM/TOS; Total thiols)", 
            "safety_issue": "No", 
            "time_frame": "0 sec, 30 second, 2 minutes, 5 minutes, 15 minutes, 30 minutes, 60 minutes"
        }, 
        "source": "Universita degli Studi di Catania", 
        "sponsors": {
            "collaborator": {
                "agency": "Laboratory for Health Protection Research", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Universita degli Studi di Catania", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}